These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1937 related items for PubMed ID: 19149076

  • 1. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E, Coban AY, Durupinar B.
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F, Manfreda G.
    Vet Microbiol; 2007 Jan 31; 119(2-4):304-10. PubMed ID: 16987619
    [Abstract] [Full Text] [Related]

  • 6. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH, Lu CD.
    Antimicrob Agents Chemother; 2007 Jun 31; 51(6):2070-7. PubMed ID: 17438056
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE.
    Antimicrob Agents Chemother; 2001 Mar 31; 45(3):883-92. PubMed ID: 11181375
    [Abstract] [Full Text] [Related]

  • 8. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G, Puech C, Lucht F, Loboguerrero M, Denis M, Dorche G.
    Pathol Biol (Paris); 1989 Oct 31; 37(8):881-7. PubMed ID: 2515519
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P, Izard D, Mullié C.
    Int J Antimicrob Agents; 2012 Jan 31; 39(1):77-80. PubMed ID: 21974858
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH, Vostrov SN, Alferova IV, Lubenko IY, Portnoy YA, Firsov AA.
    Int J Antimicrob Agents; 2004 Aug 31; 24(2):173-7. PubMed ID: 15288317
    [Abstract] [Full Text] [Related]

  • 12. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.
    Wisplinghoff H, Schmitt R, Wöhrmann A, Stefanik D, Seifert H.
    J Hosp Infect; 2007 Jun 31; 66(2):174-81. PubMed ID: 17498843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Supp DM, Gardner J, Klingenberg JM, Neely AN.
    Burns; 2009 Nov 31; 35(7):949-55. PubMed ID: 19501982
    [Abstract] [Full Text] [Related]

  • 15. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2009 Sep 31; 57():636, 638-40, 645. PubMed ID: 20214000
    [Abstract] [Full Text] [Related]

  • 16. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
    Cortez-Cordova J, Kumar A.
    Int J Antimicrob Agents; 2011 May 31; 37(5):420-4. PubMed ID: 21377839
    [Abstract] [Full Text] [Related]

  • 17. [A study on the active efflux mechanism in Staphylococcus aureus resistant to quinolone].
    Xu F, Duan DQ, Lin YG.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun 31; 27(6):403-6. PubMed ID: 15256091
    [Abstract] [Full Text] [Related]

  • 18. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B, Gill A, Amyes SG, Gülay Z.
    Mikrobiyol Bul; 2003 Jun 31; 37(2-3):125-30. PubMed ID: 14593893
    [Abstract] [Full Text] [Related]

  • 19. [Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates].
    Güler G, Eraç B.
    Mikrobiyol Bul; 2016 Apr 31; 50(2):278-86. PubMed ID: 27175500
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the in vitro susceptibility and emergence of mutants resistant to ciprofloxacin among multidrug resistant clinical isolates.
    Lopes CA, Mendes RP, Curi PC, Watanabe DS, Decarlis RM, Horácio A, Michelin LA, Placidelli BA.
    Rev Latinoam Microbiol; 1993 Apr 31; 35(4):345-9. PubMed ID: 8066328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.